- TLSI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
425 Filing
TriSalus Life Sciences (TLSI) 425Business combination disclosure
Filed: 21 Dec 22, 9:04am
Exhibit 99.2
TriSalus Corporate Twitter Post
Listen to Dr. Richard Carvajal, member of our scientific advisory board and investigator on the PERIO™-01 #clinicaltrial, discuss challenges of treating #livercancer, our investigational platform, and early findings from the PERIO™ trials below👇 https://youtu.be/zvgCMqUcZ-M
TriSalus Corporate LinkedIn Post
Listen to Dr. @Richard Carvajal, member of our scientific advisory board and investigator on the PERIO™-01 #clinicaltrial, discuss the challenges of treating #livercancer, what makes our investigational platform unique, and early findings from the ongoing PERIOTM clinical trials below 👇 https://youtu.be/zvgCMqUcZ-M
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.